ABSA International
ABSA International

Resources with keywords: AR/AMR



Klebsiella pneumoniae Carbapenemase–Producing Enterobacterales Infection and Colonization in a Long-Term Care Facility — Ontario, Canada, May 2024–January 2025
CDC / MMWR

Aloosh M, Saeed HM, Mataseje LF
KPC-producing Klebsiella pneumoniae transmission documented in a long-term care facility, underscoring HCW role in CRE transmission. In the U.S., CRE infections surged 69% in 2025; NDM-producing strains increased 461%. Healthcare workers in ICUs, wound care, and catheter management are at highest occupational exposure risk. Contact precautions, dedicated equipment, and environmental decontamination are the primary control measures. Clinical laboratory staff should handle CRE cultures under BSL-2 containment.

Emergence of Extensively Drug-Resistant Shigellosis — United States, 2011–2023
CDC / MMWR

Logan N, Birhane MG, McDonald SL, et al.
Since 2015, a growing proportion of Shigella cases have been caused by extensively drug-resistant (XDR) Shigella species, defined as being resistant to ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole. No FDA–approved oral antimicrobial agents are available to treat these XDR infections.

WHO warns of widespread resistance to common antibiotics worldwide
WHO
13 October 2025

One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new WHO report.

Clinical Overview of Drug-Resistant Tuberculosis Disease
CDC

Drug-resistant TB is transmitted in the same way as drug-susceptible TB. However, delays in the recognition of drug resistance or delays in access to effective anti-TB drugs may increase transmission and further development of drug resistance.

US Department of Agriculture (USDA) Strategy to Address Antimicrobial Resistance 2023
USDA

The purpose of this Strategy is to serve as a guide to USDA agencies and their collaborators on priorities to accelerate our understanding of and minimize the risk from AMR, focusing on the terrestrial and aquatic food and agriculture sector.

The WHO AWaRe (Access, Watch, Reserve) antibiotic book
World Health Organization (WHO)

The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides information on antibiotis, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults.

keywords: AR/AMR, children
Cluster of Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Among Patients in an Adult Intensive Care Unit — Idaho, 2021–2022
CDC/MMWR
4 August 2023

Cahill ME, Jaworski M, Harcy V, et al
Antibiotic resistant P. aeruginosa was found in patients treated in an ICU months apart; multifaceted interventions, including sink hygiene practices, engineering controls, and administrative controls, are critical to limiting multidrug-resistant organism spread in health care settings.

Infectious: Pathogens and How We Fight Them
CDC / Emerging Infectious Diseases
7 April 2023

John S. Tregoning, PhD
This book celebrates the research dedicated to understanding and controlling harmful microbes.

Dissemination of carbapenemase-producing Enterobacterales through wastewater and gulls at a wastewater treatment plant in Sweden
Science of the Total Environment
9 May 2023

Woksepp H, Karlsson K, Börjesson S, Karlsson Lindsjö O, Söderlund R, Bonnedahl J
The report includes the detection of carbapenemase-producing Enterobacterales (CPE) isolated from Swedish wastewater and gull faeces

Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears
CDC Health Alert Network (HAN)
1 February 2023
Go to Top